Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2684

Actual shortage: 240 (9%)
Anticipated shortage: 0 (0%)
Avoided shortage: 9 (0%)
Resolved: 2435 (91%)

Discontinuation Reports

250

To be discontinued: 3 (1%)
Discontinued: 247 (99%)
Reversed: 0 (0%)

Late reports

330 (11%)

Overdue reports

27 (11%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
OXALIPLATIN INJECTION 5MG SOLUTION Resolved 2019-06-27 2019-08-21 87684
RATIO-IPRA SAL UDV 0.5MG 2.5MG SOLUTION Resolved 2019-07-02 2019-07-16 88167
FLUDARABINE PHOSPHATE FOR INJECTION 25MG SOLUTION Resolved 2019-08-06 2019-11-19 90935
EPIRUBICIN FOR INJECTION 2MG SOLUTION Resolved 2019-08-22 2019-10-24 92180
VINBLASTINE SULPHATE INJECTION 1MG SOLUTION Resolved 2019-08-22 2019-10-10 92198
ACT LATANOPROST/TIMOLOL 5MG 50MCG SOLUTION Resolved 2019-08-22 2019-10-24 92229
TEVA-LATANOPROST 0.05MG SOLUTION Resolved 2019-09-05 2020-07-10 93159
OXALIPLATIN INJECTION 5MG SOLUTION Resolved 2019-09-12 2019-11-22 93650
OXALIPLATIN INJECTION 5MG SOLUTION Resolved 2019-09-26 2019-11-14 94840
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2019-10-03 2019-10-10 95373
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2019-10-03 2019-10-10 95378
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2019-10-03 2019-11-01 95381
ACT PROGESTERONE INJECTION 50MG SOLUTION Resolved 2019-10-24 2020-05-14 97147
VINCRISTINE SULFATE INJECTION 1MG SOLUTION Resolved 2019-11-07 2020-02-21 98179
VINBLASTINE SULPHATE INJECTION 1MG SOLUTION Resolved 2019-11-07 2020-01-27 98185
CISPLATIN INJECTION 1.0MG SOLUTION Resolved 2019-11-07 2020-05-29 98188
FLUDARABINE PHOSPHATE FOR INJECTION 25MG SOLUTION Resolved 2019-11-21 2020-01-09 99441
VINCRISTINE SULFATE INJECTION 1MG SOLUTION Resolved 2019-11-28 2020-06-25 99955
TEVA-COMBO STERINEBS 0.5MG 2.5MG SOLUTION Resolved 2019-12-19 2020-09-03 101702
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2020-01-09 2020-02-21 102893

Showing 721 to 740 of 2684

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-ROSUVASTATIN 5MG TABLET Discontinued 2022-03-25 2022-03-26 157428
TEVA-ROSUVASTATIN 10MG TABLET Discontinued 2022-03-25 2022-03-26 157431
TEVA-ROSUVASTATIN 20MG TABLET Discontinued 2022-03-25 2022-03-26 157434
TEVA-ROSUVASTATIN 40MG TABLET Discontinued 2022-03-25 2022-03-26 157437
TEVA-IRBESARTAN 75MG TABLET Discontinued 2024-04-01 2024-04-01 224049
NOVAMOXIN 125MG TABLET (CHEWABLE) Discontinued 2019-04-11 2019-04-11 81321
NOVAMOXIN 125MG TABLET (CHEWABLE) Discontinued 2019-10-25 2019-10-26 97251
NOVASEN 325MG TABLET (DELAYED-RELEASE) Discontinued 2018-10-12 2018-10-12 63955
NOVASEN 325MG TABLET (DELAYED-RELEASE) Discontinued 2018-10-12 2018-10-12 63959
NOVASEN 650MG TABLET (DELAYED-RELEASE) Discontinued 2018-10-12 2018-10-12 63964
TEVA-RABEPRAZOLE EC 20MG TABLET (DELAYED-RELEASE) Discontinued 2020-07-10 2020-07-10 120015
TEVA-RABEPRAZOLE EC 10MG TABLET (DELAYED-RELEASE) Discontinued 2020-07-10 2020-07-10 120018
TEVA-PANTOPRAZOLE MAGNESIUM 40MG TABLET (DELAYED-RELEASE) Discontinued 2021-02-12 2021-02-12 133891
TEVA-DIVALPROEX 125MG TABLET (ENTERIC-COATED) Discontinued 2019-10-25 2019-10-26 97232
TEVA-DIVALPROEX 250MG TABLET (ENTERIC-COATED) Discontinued 2019-10-25 2019-10-26 97235
TEVA-DIVALPROEX 500MG TABLET (ENTERIC-COATED) Discontinued 2019-10-25 2019-10-26 97238
TEVA-DICLOFENAC EC 25MG TABLET (ENTERIC-COATED) Discontinued 2024-01-25 2024-01-26 217254
ACT OXYCODONE CR 10MG TABLET (EXTENDED-RELEASE) Discontinued 2018-10-12 2018-10-12 63983
ACT OXYCODONE CR 20MG TABLET (EXTENDED-RELEASE) Discontinued 2018-10-12 2018-10-12 63986
ACT OXYCODONE CR 40MG TABLET (EXTENDED-RELEASE) Discontinued 2018-10-12 2018-10-12 63989

Showing 221 to 240 of 250